Edwards Lifesciences Corporation Common Stock vs Veeva Systems — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Veeva Systems trades at $284.9 (market cap $45.74B). The key difference: Edwards Lifesciences Corporation Common Stock and Veeva Systems are close in size by market cap, and Veeva Systems is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | VEEV | |
|---|---|---|
Market Cap | $49.44B | $45.74B |
Volume | 3,508,027 | 1,118,315 |
Sector | Health | Technology |
52-Week High | $95.18 | $299.10 |
52-Week Low | $72.65 | $151.43 |
Enterprise Value | $45.90B | $38.65B |
Typical Hold Time | — | 5 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →